English
Seagen is a global biotechnology company dedicated to revolutionizing cancer care. We’re developing transformative therapies that make a meaningful difference in people’s lives.
As a pioneer in antibody-drug conjugates (ADCs), Seagen has led the way in novel cancer therapeutics for more than 20 years. We’re committed to discovering safe and effective solutions to challenging clinical needs. Today, our research efforts are dedicated to advancing a pipeline of innovative therapies for solid tumours and blood-related cancers.
Seagen Germany GmbH
Maximilianstrasse 13, 3 Stock
80539 München
DEUTSCHLAND
Telephone: 0049 89 3803 691 5
Fax: 0800 – 554 141 0/ 00800-117 711 00
Email: seagen@arvato-scs.com
AG München HRB 248466 Deutschland
Geschäftsführer: Audrey Sherman, Lee J. Heeson
UID-Nr. DE326948917
Auftraggannahme/Customer Service
0049 89 3803 691 5
0800 – 554 141 0/ 00800-117 711 00
seagen@arvato-scs.com
Business Hours:
Monday - Friday: 8:30 a.m. - 5:00 p.m. (CET)
Order Acceptance.
by 3 p.m. (CET) for same-day processing (Mon - Fri only)
after 3 p.m. (CET) for following day processing (Mon - Thu only)
